|
|
Volumn 15, Issue 5, 1995, Pages 334-340
|
|
Haloperidol dose and blood level variability: Toxicity and interindividual and intraindividual variability in the nonresponder patient in the clinical practice setting
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HALOPERIDOL;
ADULT;
ARTICLE;
CATATONIA;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFUSION;
DRUG BLOOD LEVEL;
FEMALE;
HUMAN;
MALE;
NEUROLEPTIC MALIGNANT SYNDROME;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
SCHIZOPHRENIA;
SEIZURE;
SIDE EFFECT;
ADMINISTRATION, ORAL;
ADULT;
ANTIPSYCHOTIC AGENTS, BUTYROPHENONE;
BIOLOGICAL AVAILABILITY;
CHRONIC DISEASE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HALOPERIDOL;
HUMAN;
LONG-TERM CARE;
MALE;
METABOLIC CLEARANCE RATE;
MIDDLE AGE;
PSYCHIATRIC STATUS RATING SCALES;
PSYCHOSES, SUBSTANCE-INDUCED;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
SUPPORT, NON-U.S. GOV'T;
|
|
EID: 0028886359
PISSN: 02710749
EISSN: None
Source Type: Journal
DOI: 10.1097/00004714-199510000-00005 Document Type: Article |
|
Times cited : (26)
|
|
References (0)
|
